Does the duration of empiric antibiotic treatment influence NEC incidence and severity relative to placental pathology?
Related Experiment Video
Updated: Jan 15, 2026

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Parvesh Mohan Garg1, Liza Konnikova2,3, Suhas G Kallapur4
1Department of Pediatrics/Neonatology, Atrium Health Wake Forest Baptist, Wake Forest School of Medicine, Winston Salem, NC, USA.
Abstract:
Necrotizing enterocolitis (NEC) remains a leading cause of mortality in preterm infants. Studies show that exposure to chorioamnionitis is associated with increased rate of NEC. The influence of the early antibiotic exposure provides contrasting findings, with a few studies demonstrating an increased risk of NEC with prenatal and postnatal antibiotic treatment, and others showing a decreased NEC risk. Far fewer reports delineate the impact of the duration of early antibiotics or the potential confounding of antibiotics by placental pathology on incidence of NEC. The provision of antibiotics following birth is associated with increased risk of NEC secondary to changes in the gut microbiome, intestinal epithelium maturation, and the intestinal barrier function. This report presents current evidence about the clinical impact of intrauterine environment and postnatal antibiotic exposure on the intestinal injury in preterm infants. We present information from our own research in conjunction with information collected from an extensive search in the databases PubMed, EMBASE, and Scopus. Both translational and prospective clinical studies are needed to fully understand the combined impact of placental pathology and postnatal antibiotic exposure on the neonatal morbidities and mortality.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Urine Studies II: Urine Culture and Sensitivity Test
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Teratogenicity

